APA (7th ed.) Citation

V, D. R., A, C., G, D. B., MD, D. P., P, V., A, D. G., . . . I, R. (2025). Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: A case report. Frontiers in oncology, 15, 1665968. https://doi.org/10.3389/fonc.2025.1665968

Chicago Style (17th ed.) Citation

V, Di Ruscio, et al. "Prolonged Overall Survival in a Child with Multimetastatic Retinoblastoma Treated with Anti-GD2 Monoclonal Antibody Dinutuximab Beta: A Case Report." Frontiers in Oncology 15 (2025): 1665968. https://doi.org/10.3389/fonc.2025.1665968.

MLA (9th ed.) Citation

V, Di Ruscio, et al. "Prolonged Overall Survival in a Child with Multimetastatic Retinoblastoma Treated with Anti-GD2 Monoclonal Antibody Dinutuximab Beta: A Case Report." Frontiers in Oncology, vol. 15, 2025, p. 1665968, https://doi.org/10.3389/fonc.2025.1665968.